FDA approves new blood test for Alzheimer’s disease
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer’s disease. It’s the fourth such…
The Hill
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from The Hill.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
The Hill (thehill.com), a Tier B publisher, filed this report on . CurrentWire published this page 3 minutes later, on .
Signal breakdown
CurrentWire ranked this story 68.2 of 100 in the snapshot this page was rendered from.
- Freshness
- 32.2 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under Health · United States · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: FDA (5).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.